25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Galapagos N.V.
Buy, Hold or Sell?

Let's analyze Galapagos N.V. together

I guess you are interested in Galapagos N.V.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Galapagos N.V.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Galapagos N.V.

I send you an email if I find something interesting about Galapagos N.V..

1. Quick Overview

1.1. Quick analysis of Galapagos N.V. (30 sec.)










1.2. What can you expect buying and holding a share of Galapagos N.V.? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€44.16
Expected worth in 1 year
€49.12
How sure are you?
52.5%

+ What do you gain per year?

Total Gains per Share
€4.95
Return On Investment
18.3%

For what price can you sell your share?

Current Price per Share
€27.12
Expected price per share
€22.00 - €34.03
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Galapagos N.V. (5 min.)




Live pricePrice per Share (EOD)
€27.12
Intrinsic Value Per Share
€-86.93 - €-23.74
Total Value Per Share
€-42.77 - €20.42

2.2. Growth of Galapagos N.V. (5 min.)




Is Galapagos N.V. growing?

Current yearPrevious yearGrowGrow %
How rich?$3.1b$2.8b$235.4m7.6%

How much money is Galapagos N.V. making?

Current yearPrevious yearGrowGrow %
Making money$77.5m-$43.2m$120.7m155.7%
Net Profit Margin25.6%-46.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Galapagos N.V. (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#25 / 961

Most Revenue
#250 / 961

Most Profit
#24 / 961
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Galapagos N.V.?

Welcome investor! Galapagos N.V.'s management wants to use your money to grow the business. In return you get a share of Galapagos N.V..

First you should know what it really means to hold a share of Galapagos N.V.. And how you can make/lose money.

Speculation

The Price per Share of Galapagos N.V. is €27.12. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Galapagos N.V..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Galapagos N.V., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €44.16. Based on the TTM, the Book Value Change Per Share is €1.24 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.24 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Galapagos N.V..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.150.6%1.184.3%-0.66-2.4%0.000.0%-0.14-0.5%
Usd Book Value Change Per Share0.250.9%1.365.0%-0.26-1.0%1.475.4%1.124.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.250.9%1.365.0%-0.26-1.0%1.475.4%1.124.1%
Usd Price Per Share25.63-33.62-43.37-81.97-75.65-
Price to Earnings Ratio42.79-18.20-44.01-14.27--6.55-
Price-to-Total Gains Ratio100.61-47.80-59.42-3,768.21-2,004.41-
Price to Book Ratio0.53-0.72-1.00-1.82-3.73-
Price-to-Total Gains Ratio100.61-47.80-59.42-3,768.21-2,004.41-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share29.785896
Number of shares33
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share1.361.47
Usd Total Gains Per Share1.361.47
Gains per Quarter (33 shares)44.8748.59
Gains per Year (33 shares)179.49194.36
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101791690194184
203593480389378
305385270583572
407187060777766
508978850972960
6010771064011661154
7012561243013611348
8014361422015551542
9016151601017491736
10017951780019441930

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%8.04.00.066.7%11.09.00.055.0%15.025.00.037.5%21.026.031.026.9%
Book Value Change Per Share4.00.00.0100.0%10.02.00.083.3%14.06.00.070.0%21.017.02.052.5%32.027.019.041.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.078.00.0%
Total Gains per Share4.00.00.0100.0%10.02.00.083.3%14.06.00.070.0%21.017.02.052.5%32.027.019.041.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Galapagos N.V. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2321.238-81%-0.239+203%1.341-83%1.019-77%
Book Value Per Share--44.16442.576+4%39.322+12%40.766+8%26.136+69%
Current Ratio--10.0489.470+6%8.232+22%8.878+13%7.729+30%
Debt To Asset Ratio--0.3220.357-10%0.450-29%0.471-32%0.348-8%
Debt To Equity Ratio--0.4740.559-15%0.820-42%0.918-48%0.610-22%
Dividend Per Share----0%-0%-0%-0%
Eps--0.1361.072-87%-0.597+538%-0.001+101%-0.125+192%
Free Cash Flow Per Share---2.007-1.737-13%-2.067+3%0.771-360%0.241-933%
Free Cash Flow To Equity Per Share---2.023-1.758-13%-2.078+3%1.787-213%1.248-262%
Gross Profit Margin--1.0000.204+391%0.135+639%0.816+23%0.914+9%
Intrinsic Value_10Y_max---23.741--------
Intrinsic Value_10Y_min---86.932--------
Intrinsic Value_1Y_max--0.480--------
Intrinsic Value_1Y_min---8.081--------
Intrinsic Value_3Y_max---0.736--------
Intrinsic Value_3Y_min---24.969--------
Intrinsic Value_5Y_max---4.579--------
Intrinsic Value_5Y_min---42.484--------
Market Cap1787129352.000+14%1538038314.0002017110231.000-24%2602441221.750-41%4945403087.716-69%4552306937.071-66%
Net Profit Margin--0.1150.256-55%-0.464+502%-0.270+334%-0.689+697%
Operating Margin---0.020-100%-0.4040%-0.3090%-0.8540%
Operating Ratio--1.7031.182+44%1.404+21%1.548+10%2.907-41%
Pb Ratio0.614+14%0.5280.723-27%1.004-47%1.822-71%3.727-86%
Pe Ratio49.725+14%42.79518.203+135%44.013-3%14.269+200%-6.549+115%
Price Per Share27.120+14%23.34030.610-24%39.493-41%74.638-69%68.877-66%
Price To Free Cash Flow Ratio-3.378-16%-2.907-4.807+65%-4.971+71%-9.470+226%-22.692+681%
Price To Total Gains Ratio116.905+14%100.61147.804+110%59.419+69%3768.213-97%2004.414-95%
Quick Ratio--9.37013.144-29%15.368-39%13.792-32%9.939-6%
Return On Assets--0.0020.016-87%-0.008+497%0.000+109%-0.013+699%
Return On Equity--0.0030.025-88%-0.016+610%-0.001+137%-0.016+612%
Total Gains Per Share--0.2321.238-81%-0.239+203%1.341-83%1.019-77%
Usd Book Value--3196376998.5003081398442.675+4%2845950380.175+12%2960643707.490+8%1896662232.675+69%
Usd Book Value Change Per Share--0.2551.360-81%-0.262+203%1.472-83%1.119-77%
Usd Book Value Per Share--48.50646.761+4%43.188+12%44.774+8%28.705+69%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.1501.177-87%-0.656+538%-0.001+101%-0.137+192%
Usd Free Cash Flow---145271042.700-125708397.675-13%-149581046.475+3%55419339.360-362%17236637.828-943%
Usd Free Cash Flow Per Share---2.205-1.908-13%-2.270+3%0.847-360%0.265-933%
Usd Free Cash Flow To Equity Per Share---2.222-1.931-13%-2.282+3%1.963-213%1.371-262%
Usd Market Cap1962804167.302+14%1689227480.2662215392166.707-24%2858261193.848-41%5431536211.238-69%4999798708.985-66%
Usd Price Per Share29.786+14%25.63433.619-24%43.375-41%81.975-69%75.648-66%
Usd Profit--9868225.50077593247.550-87%-43203003.375+538%-3844434.405+139%-10926108.060+211%
Usd Revenue--85527915.90014060436.600+508%153801538.800-44%142856265.405-40%90942095.580-6%
Usd Total Gains Per Share--0.2551.360-81%-0.262+203%1.472-83%1.119-77%
 EOD+5 -3MRQTTM+11 -23YOY+26 -75Y+15 -1810Y+16 -17

3.3 Fundamental Score

Let's check the fundamental score of Galapagos N.V. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1549.725
Price to Book Ratio (EOD)Between0-10.614
Net Profit Margin (MRQ)Greater than00.115
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than19.370
Current Ratio (MRQ)Greater than110.048
Debt to Asset Ratio (MRQ)Less than10.322
Debt to Equity Ratio (MRQ)Less than10.474
Return on Equity (MRQ)Greater than0.150.003
Return on Assets (MRQ)Greater than0.050.002
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of Galapagos N.V. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.656
Ma 20Greater thanMa 5026.460
Ma 50Greater thanMa 10025.112
Ma 100Greater thanMa 20024.810
OpenGreater thanClose27.360
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Galapagos N.V.

Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.

Fundamental data was last updated by Penke on 2024-10-01 17:32:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Galapagos N.V. earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Galapagos N.V. to the Biotechnology industry mean.
  • A Net Profit Margin of 11.5% means that €0.12 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Galapagos N.V.:

  • The MRQ is 11.5%. The company is making a huge profit. +2
  • The TTM is 25.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ11.5%TTM25.6%-14.0%
TTM25.6%YOY-46.4%+72.0%
TTM25.6%5Y-27.0%+52.6%
5Y-27.0%10Y-68.9%+41.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.5%-115.9%+127.4%
TTM25.6%-189.7%+215.3%
YOY-46.4%-205.7%+159.3%
5Y-27.0%-363.4%+336.4%
10Y-68.9%-469.8%+400.9%
4.3.1.2. Return on Assets

Shows how efficient Galapagos N.V. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Galapagos N.V. to the Biotechnology industry mean.
  • 0.2% Return on Assets means that Galapagos N.V. generated €0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Galapagos N.V.:

  • The MRQ is 0.2%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.6%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.2%TTM1.6%-1.4%
TTM1.6%YOY-0.8%+2.5%
TTM1.6%5Y0.0%+1.6%
5Y0.0%10Y-1.3%+1.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2%-10.9%+11.1%
TTM1.6%-11.7%+13.3%
YOY-0.8%-11.2%+10.4%
5Y0.0%-12.9%+12.9%
10Y-1.3%-14.4%+13.1%
4.3.1.3. Return on Equity

Shows how efficient Galapagos N.V. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Galapagos N.V. to the Biotechnology industry mean.
  • 0.3% Return on Equity means Galapagos N.V. generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Galapagos N.V.:

  • The MRQ is 0.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.3%TTM2.5%-2.2%
TTM2.5%YOY-1.6%+4.1%
TTM2.5%5Y-0.1%+2.6%
5Y-0.1%10Y-1.6%+1.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3%-14.1%+14.4%
TTM2.5%-15.9%+18.4%
YOY-1.6%-13.6%+12.0%
5Y-0.1%-19.0%+18.9%
10Y-1.6%-19.3%+17.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Galapagos N.V..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Galapagos N.V. is operating .

  • Measures how much profit Galapagos N.V. makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Galapagos N.V. to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Galapagos N.V.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.0%-2.0%
TTM2.0%YOY-40.4%+42.4%
TTM2.0%5Y-30.9%+32.9%
5Y-30.9%10Y-85.4%+54.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--258.6%+258.6%
TTM2.0%-292.1%+294.1%
YOY-40.4%-222.0%+181.6%
5Y-30.9%-385.5%+354.6%
10Y-85.4%-497.6%+412.2%
4.3.2.2. Operating Ratio

Measures how efficient Galapagos N.V. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.70 means that the operating costs are €1.70 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Galapagos N.V.:

  • The MRQ is 1.703. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.182. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.703TTM1.182+0.521
TTM1.182YOY1.404-0.223
TTM1.1825Y1.548-0.366
5Y1.54810Y2.907-1.360
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7032.649-0.946
TTM1.1823.101-1.919
YOY1.4043.298-1.894
5Y1.5485.011-3.463
10Y2.9076.530-3.623
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Galapagos N.V..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Galapagos N.V. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 10.05 means the company has €10.05 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Galapagos N.V.:

  • The MRQ is 10.048. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.470. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ10.048TTM9.470+0.577
TTM9.470YOY8.232+1.239
TTM9.4705Y8.878+0.593
5Y8.87810Y7.729+1.149
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.0483.793+6.255
TTM9.4704.010+5.460
YOY8.2324.740+3.492
5Y8.8785.980+2.898
10Y7.7296.318+1.411
4.4.3.2. Quick Ratio

Measures if Galapagos N.V. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Galapagos N.V. to the Biotechnology industry mean.
  • A Quick Ratio of 9.37 means the company can pay off €9.37 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Galapagos N.V.:

  • The MRQ is 9.370. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 13.144. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ9.370TTM13.144-3.774
TTM13.144YOY15.368-2.224
TTM13.1445Y13.792-0.648
5Y13.79210Y9.939+3.853
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.3703.349+6.021
TTM13.1443.580+9.564
YOY15.3684.735+10.633
5Y13.7925.922+7.870
10Y9.9396.499+3.440
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Galapagos N.V..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Galapagos N.V. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Galapagos N.V. to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.32 means that Galapagos N.V. assets are financed with 32.2% credit (debt) and the remaining percentage (100% - 32.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Galapagos N.V.:

  • The MRQ is 0.322. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.357. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.322TTM0.357-0.035
TTM0.357YOY0.450-0.093
TTM0.3575Y0.471-0.114
5Y0.47110Y0.348+0.122
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3220.340-0.018
TTM0.3570.341+0.016
YOY0.4500.309+0.141
5Y0.4710.365+0.106
10Y0.3480.382-0.034
4.5.4.2. Debt to Equity Ratio

Measures if Galapagos N.V. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Galapagos N.V. to the Biotechnology industry mean.
  • A Debt to Equity ratio of 47.4% means that company has €0.47 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Galapagos N.V.:

  • The MRQ is 0.474. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.559. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.474TTM0.559-0.085
TTM0.559YOY0.820-0.260
TTM0.5595Y0.918-0.358
5Y0.91810Y0.610+0.308
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4740.393+0.081
TTM0.5590.437+0.122
YOY0.8200.373+0.447
5Y0.9180.449+0.469
10Y0.6100.489+0.121
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Galapagos N.V. generates.

  • Above 15 is considered overpriced but always compare Galapagos N.V. to the Biotechnology industry mean.
  • A PE ratio of 42.79 means the investor is paying €42.79 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Galapagos N.V.:

  • The EOD is 49.725. Based on the earnings, the company is overpriced. -1
  • The MRQ is 42.795. Based on the earnings, the company is overpriced. -1
  • The TTM is 18.203. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD49.725MRQ42.795+6.931
MRQ42.795TTM18.203+24.592
TTM18.203YOY44.013-25.810
TTM18.2035Y14.269+3.934
5Y14.26910Y-6.549+20.817
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD49.725-2.319+52.044
MRQ42.795-2.392+45.187
TTM18.203-2.926+21.129
YOY44.013-3.428+47.441
5Y14.269-5.926+20.195
10Y-6.549-6.207-0.342
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Galapagos N.V.:

  • The EOD is -3.378. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.907. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.807. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.378MRQ-2.907-0.471
MRQ-2.907TTM-4.807+1.900
TTM-4.807YOY-4.971+0.164
TTM-4.8075Y-9.470+4.663
5Y-9.47010Y-22.692+13.222
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.378-2.989-0.389
MRQ-2.907-3.184+0.277
TTM-4.807-3.470-1.337
YOY-4.971-4.583-0.388
5Y-9.470-8.064-1.406
10Y-22.692-8.680-14.012
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Galapagos N.V. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.53 means the investor is paying €0.53 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Galapagos N.V.:

  • The EOD is 0.614. Based on the equity, the company is cheap. +2
  • The MRQ is 0.528. Based on the equity, the company is cheap. +2
  • The TTM is 0.723. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.614MRQ0.528+0.086
MRQ0.528TTM0.723-0.194
TTM0.723YOY1.004-0.281
TTM0.7235Y1.822-1.099
5Y1.82210Y3.727-1.905
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.6141.968-1.354
MRQ0.5281.972-1.444
TTM0.7232.204-1.481
YOY1.0042.370-1.366
5Y1.8223.574-1.752
10Y3.7274.216-0.489
4.6.2. Total Gains per Share

2.4. Latest News of Galapagos N.V.

Does Galapagos N.V. still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Galapagos N.V. to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2024-10-07
07:00
Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growthRead
2024-09-16
22:01
Galapagos receives transparency notification from EcoR1 CapitalRead
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets4,290,367
Total Liabilities1,380,072
Total Stockholder Equity2,910,295
 As reported
Total Liabilities 1,380,072
Total Stockholder Equity+ 2,910,295
Total Assets = 4,290,367

Assets

Total Assets4,290,367
Total Current Assets3,665,186
Long-term Assets625,181
Total Current Assets
Cash And Cash Equivalents 72,328
Short-term Investments 3,358,092
Net Receivables 60,024
Inventory 63,364
Other Current Assets 29,527
Total Current Assets  (as reported)3,665,186
Total Current Assets  (calculated)3,583,335
+/- 81,851
Long-term Assets
Property Plant Equipment 128,491
Goodwill 69,787
Long Term Investments 51,378
Intangible Assets 182,547
Long-term Assets Other 17,690
Long-term Assets  (as reported)625,181
Long-term Assets  (calculated)449,893
+/- 175,288

Liabilities & Shareholders' Equity

Total Current Liabilities364,781
Long-term Liabilities1,015,291
Total Stockholder Equity2,910,295
Total Current Liabilities
Accounts payable 128,312
Total Current Liabilities  (as reported)364,781
Total Current Liabilities  (calculated)128,312
+/- 236,469
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt10,873
Long-term Liabilities Other 29,808
Long-term Liabilities  (as reported)1,015,291
Long-term Liabilities  (calculated)40,681
+/- 974,610
Total Stockholder Equity
Total Stockholder Equity (as reported)2,910,295
Total Stockholder Equity (calculated)0
+/- 2,910,295
Other
Capital Stock293,937
Common Stock Shares Outstanding 65,897
Net Invested Capital 2,910,295
Net Working Capital 3,300,405



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-31
> Total Assets 
15,613
32,890
32,890
0
81,563
74,389
74,389
156,261
167,646
147,762
147,762
148,724
148,724
119,905
119,905
118,824
118,824
106,216
106,216
143,709
143,709
139,736
139,736
193,961
193,961
152,989
152,989
161,055
161,055
243,337
243,338
235,329
235,329
276,228
276,228
287,374
287,374
304,980
304,980
0
270,467
0
488,263
461,048
442,514
1,079,287
1,066,524
1,043,092
1,083,338
1,072,814
1,368,355
1,331,373
1,286,274
1,229,864
1,204,348
1,485,551
1,439,496
1,400,200
1,357,848
5,851,752
6,068,609
5,992,406
5,851,564
5,721,087
5,717,731
5,615,059
5,430,617
5,331,987
5,193,160
5,100,315
5,040,085
4,972,070
4,734,351
4,632,172
4,522,340
4,451,336
4,357,396
4,361,379
4,290,367
4,290,3674,361,3794,357,3964,451,3364,522,3404,632,1724,734,3514,972,0705,040,0855,100,3155,193,1605,331,9875,430,6175,615,0595,717,7315,721,0875,851,5645,992,4066,068,6095,851,7521,357,8481,400,2001,439,4961,485,5511,204,3481,229,8641,286,2741,331,3731,368,3551,072,8141,083,3381,043,0921,066,5241,079,287442,514461,048488,2630270,4670304,980304,980287,374287,374276,228276,228235,329235,329243,338243,337161,055161,055152,989152,989193,961193,961139,736139,736143,709143,709106,216106,216118,824118,824119,905119,905148,724148,724147,762147,762167,646156,26174,38974,38981,563032,89032,89015,613
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
59,849
0
44,623
0
84,686
0
58,251
0
109,223
0
67,403
0
65,562
0
143,735
0
132,727
0
168,039
0
176,653
0
254,894
0
213,603
0
422,245
397,561
374,470
1,007,664
992,267
962,967
1,007,232
992,122
1,284,957
1,243,839
1,197,647
1,135,735
1,107,881
1,390,400
1,328,851
1,259,244
1,208,604
5,651,013
5,865,927
5,780,264
5,622,005
5,463,769
5,369,347
5,310,922
5,129,494
5,015,997
4,861,854
4,750,700
4,533,192
4,462,397
4,236,850
4,155,294
4,032,147
3,956,092
3,861,589
3,786,470
3,665,186
3,665,1863,786,4703,861,5893,956,0924,032,1474,155,2944,236,8504,462,3974,533,1924,750,7004,861,8545,015,9975,129,4945,310,9225,369,3475,463,7695,622,0055,780,2645,865,9275,651,0131,208,6041,259,2441,328,8511,390,4001,107,8811,135,7351,197,6471,243,8391,284,957992,1221,007,232962,967992,2671,007,664374,470397,561422,2450213,6030254,8940176,6530168,0390132,7270143,735065,562067,4030109,223058,251084,686044,623059,8490000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27,316
0
18,745
0
47,391
0
27,165
0
40,397
0
49,845
0
32,555
0
122,613
0
94,647
0
136,709
0
141,481
0
231,531
0
187,712
0
397,477
366,545
340,314
978,334
960,481
930,807
973,241
953,385
1,262,061
1,218,856
1,151,211
1,108,186
1,066,766
1,343,668
1,290,796
1,222,901
1,147,923
5,599,787
1,861,616
2,743,573
2,384,220
2,087,797
2,135,187
2,553,950
2,642,639
2,834,378
2,233,368
1,254,279
972,796
675,519
508,117
124,135
98,024
159,375
166,803
73,372
72,328
72,32873,372166,803159,37598,024124,135508,117675,519972,7961,254,2792,233,3682,834,3782,642,6392,553,9502,135,1872,087,7972,384,2202,743,5731,861,6165,599,7871,147,9231,222,9011,290,7961,343,6681,066,7661,108,1861,151,2111,218,8561,262,061953,385973,241930,807960,481978,334340,314366,545397,4770187,7120231,5310141,4810136,709094,6470122,613032,555049,845040,397027,165047,391018,745027,3160000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,919,216
2,978,805
3,182,276
3,220,805
3,026,278
2,560,743
2,363,969
2,039,787
2,469,809
3,389,098
3,456,184
3,686,557
3,585,945
3,865,915
3,776,913
3,652,333
3,517,698
3,484,560
3,358,092
3,358,0923,484,5603,517,6983,652,3333,776,9133,865,9153,585,9453,686,5573,456,1843,389,0982,469,8092,039,7872,363,9692,560,7433,026,2783,220,8053,182,2762,978,8053,919,216000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
2,169
2,120
2,120
0
9,786
5,729
5,729
24,846
24,847
24,702
24,702
26,500
23,581
19,761
19,761
26,427
26,616
20,131
20,131
32,489
31,984
26,173
26,173
63,546
63,484
14,304
14,304
28,857
30,010
16,083
16,083
33,242
33,242
26,540
26,540
31,979
31,979
20,061
20,061
0
13,795
0
11,801
19,163
16,057
15,075
17,625
18,127
23,478
26,164
15,642
17,740
41,788
20,086
33,762
37,006
33,533
26,992
53,711
42,388
80,109
49,180
45,190
139,299
173,400
180,347
113,600
126,802
128,601
78,521
64,058
54,374
77,344
67,569
67,576
73,044
65,655
54,611
60,024
60,02454,61165,65573,04467,57667,56977,34454,37464,05878,521128,601126,802113,600180,347173,400139,29945,19049,18080,10942,38853,71126,99233,53337,00633,76220,08641,78817,74015,64226,16423,47818,12717,62515,07516,05719,16311,801013,795020,06120,06131,97931,97926,54026,54033,24233,24216,08316,08330,01028,85714,30414,30463,48463,54626,17326,17331,98432,48920,13120,13126,61626,42719,76119,76123,58126,50024,70224,70224,84724,8465,7295,7299,78602,1202,1202,169
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
2,919
0
0
2,532
2,343
1,604
1,604
2,990
3,495
3,139
3,139
3,843
3,905
2,193
2,193
3,647
2,495
4,522
4,522
4,634
4,634
4,520
4,520
2,944
5,091
3,005
3,005
0
11,815
0
5,751
4,653
-1
5,642
6,981
6,848
1
8,215
6,936
6,939
1
7,170
7,086
7,432
4,246
9,351
6,970
8,838
4,731
8,706
10,319
15,868
34,127
15,882
9,286
15,030
-1
10,404
13,146
20,437
2
27,897
40,766
15,735
37,455
15,711
29,527
29,52715,71137,45515,73540,76627,897220,43713,14610,404-115,0309,28615,88234,12715,86810,3198,7064,7318,8386,9709,3514,2467,4327,0867,17016,9396,9368,21516,8486,9815,642-14,6535,751011,81503,0053,0055,0912,9444,5204,5204,6344,6344,5224,5222,4953,6472,1932,1933,9053,8433,1393,1393,4952,9901,6041,6042,3432,532002,919000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58,975
0
61,593
0
59,023
0
81,485
0
84,738
0
85,586
0
95,493
0
99,601
0
102,602
0
108,189
0
110,721
0
50,086
0
56,864
0
66,018
63,487
68,044
71,624
74,257
80,127
76,107
80,692
83,398
0
88,627
94,129
96,467
95,151
110,645
140,956
149,244
200,739
202,682
212,142
229,559
257,318
348,384
304,136
301,123
315,990
331,306
349,615
506,893
509,673
497,501
476,877
490,193
495,244
495,807
574,909
625,181
625,181574,909495,807495,244490,193476,877497,501509,673506,893349,615331,306315,990301,123304,136348,384257,318229,559212,142202,682200,739149,244140,956110,64595,15196,46794,12988,627083,39880,69276,10780,12774,25771,62468,04463,48766,018056,864050,0860110,7210108,1890102,602099,601095,493085,586084,738081,485059,023061,593058,9750000000000000000
       Property Plant Equipment 
2,625
2,669
2,669
0
9,399
9,939
9,939
25,540
25,965
26,013
26,013
22,914
22,914
21,135
21,135
20,293
20,293
20,542
20,542
19,285
19,285
20,473
20,473
23,886
23,886
20,310
20,310
19,524
19,523
19,253
19,253
18,099
18,099
17,273
17,273
19,525
19,525
10,761
10,761
0
10,091
0
11,178
12,577
13,783
14,110
15,091
15,032
14,959
15,064
15,506
15,279
16,692
16,971
17,854
18,113
23,138
49,542
51,180
61,883
66,054
66,979
73,786
94,661
103,379
111,294
111,900
123,637
137,513
145,896
148,866
150,394
154,253
134,888
134,728
136,803
126,321
125,059
128,491
128,491125,059126,321136,803134,728134,888154,253150,394148,866145,896137,513123,637111,900111,294103,37994,66173,78666,97966,05461,88351,18049,54223,13818,11317,85416,97116,69215,27915,50615,06414,95915,03215,09114,11013,78312,57711,178010,091010,76110,76119,52519,52517,27317,27318,09918,09919,25319,25319,52319,52420,31020,31023,88623,88620,47320,47319,28519,28520,54220,54220,29320,29321,13521,13522,91422,91426,01326,01325,96525,5409,9399,9399,39902,6692,6692,625
       Goodwill 
0
0
0
0
29,481
29,112
29,112
32,996
35,560
35,948
35,948
33,952
33,952
33,952
33,952
33,751
33,751
33,751
33,751
33,751
33,751
42,710
42,710
42,380
42,380
38,880
38,880
38,880
38,880
38,314
38,314
37,667
37,667
39,240
39,240
39,239
39,239
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
174,288
174,994
69,813
69,672
69,678
69,863
69,557
69,715
69,787
69,78769,71569,55769,86369,67869,67269,813174,994174,28800000000000000000000000000000000039,23939,23939,24039,24037,66737,66738,31438,31438,88038,88038,88038,88042,38042,38042,71042,71033,75133,75133,75133,75133,75133,75133,95233,95233,95233,95235,94835,94835,56032,99629,11229,11229,4810000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46,524
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,754
0
0
0
6,000
0
0
0
11,275
0
0
0
8,951
0
0
0
0
0
0
0
0
0
0
0
13,575
0
51,378
51,378013,575000000000008,95100011,2750006,0000001,754000000000000000000046,52400000000000000000000000000000000
       Intangible Assets 
447
422
422
0
34,350
33,690
33,690
42,445
53,404
53,164
53,164
40,042
40,042
40,019
40,019
37,910
4,159
37,960
4,209
37,231
3,480
58,248
15,538
55,914
13,534
50,068
11,188
49,494
10,614
48,135
9,821
47,091
9,426
47,768
8,528
47,071
7,833
1,862
1,862
0
2,016
0
1,575
1,517
1,552
1,382
1,226
1,150
1,025
963
859
747
2,498
2,555
1,403
2,058
3,631
6,497
7,191
23,492
24,925
33,856
39,254
41,114
67,566
65,738
63,072
59,623
60,103
0
32,346
38,493
146,353
140,914
136,470
132,313
127,906
125,998
182,547
182,547125,998127,906132,313136,470140,914146,35338,49332,346060,10359,62363,07265,73867,56641,11439,25433,85624,92523,4927,1916,4973,6312,0581,4032,5552,4987478599631,0251,1501,2261,3821,5521,5171,57502,01601,8621,8627,83347,0718,52847,7689,42647,0919,82148,13510,61449,49411,18850,06813,53455,91415,53858,2483,48037,2314,20937,9604,15937,91040,01940,01940,04240,04253,16453,16453,40442,44533,69033,69034,3500422422447
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
772
0
52
0
807
0
1,064
0
1,280
0
14,041
0
24,310
0
28,676
0
417
0
41,252
0
39,346
0
1
0
520
0
865
1,594
1,599
1,603
1,692
4,261
3,978
4,015
3,834
0
3,458
3,339
3,663
3,700
7,919
6,377
5,713
5,993
96,223
13,945
9,522
8,647
164,013
4,465
4,422
4,455
2,472
140,531
8,388
7,832
1,209
5,702
17,927
16,912
157,322
65,516
17,690
17,69065,516157,32216,91217,9275,7021,2097,8328,388140,5312,4724,4554,4224,465164,0138,6479,52213,94596,2235,9935,7136,3777,9193,7003,6633,3393,45803,8344,0153,9784,2611,6921,6031,5991,594865052001039,346041,2520417028,676024,310014,04101,28001,064080705207720000000000000000
> Total Liabilities 
5,246
5,044
5,044
0
20,427
18,591
18,591
46,719
58,104
43,574
43,574
50,098
50,098
31,674
31,674
34,500
34,500
26,975
26,975
34,832
34,832
36,555
36,555
45,455
45,454
34,697
34,697
42,679
42,679
130,997
130,998
116,882
116,882
108,216
108,216
120,237
120,237
79,965
79,965
0
64,332
0
44,808
42,258
77,515
350,742
336,724
334,271
324,637
324,664
299,329
294,441
274,291
330,519
318,689
297,329
225,247
224,445
214,481
3,316,471
3,192,951
3,152,365
3,078,301
3,009,004
3,047,376
2,913,597
2,767,144
2,714,604
2,549,798
2,453,726
2,393,187
2,281,719
2,208,325
2,067,568
1,938,392
1,829,776
1,561,830
1,466,371
1,380,072
1,380,0721,466,3711,561,8301,829,7761,938,3922,067,5682,208,3252,281,7192,393,1872,453,7262,549,7982,714,6042,767,1442,913,5973,047,3763,009,0043,078,3013,152,3653,192,9513,316,471214,481224,445225,247297,329318,689330,519274,291294,441299,329324,664324,637334,271336,724350,74277,51542,25844,808064,332079,96579,965120,237120,237108,216108,216116,882116,882130,998130,99742,67942,67934,69734,69745,45445,45536,55536,55534,83234,83226,97526,97534,50034,50031,67431,67450,09850,09843,57443,57458,10446,71918,59118,59120,42705,0445,0445,246
   > Total Current Liabilities 
3,608
3,688
3,688
0
14,065
12,305
12,305
29,655
29,278
22,704
22,704
43,361
43,361
25,532
25,532
29,751
29,751
22,787
22,787
31,344
31,344
28,053
28,053
38,223
38,223
27,818
27,818
35,360
35,360
124,367
124,367
109,014
109,014
99,294
99,294
112,559
112,559
75,977
75,977
0
60,356
0
40,299
37,251
72,412
104,736
111,549
129,826
103,791
127,984
130,678
154,531
171,699
223,631
246,586
269,102
219,905
199,450
188,712
631,300
571,793
622,626
618,538
601,744
635,274
605,362
576,985
575,494
566,474
562,896
550,725
532,207
522,538
522,904
475,073
444,036
428,223
382,214
364,781
364,781382,214428,223444,036475,073522,904522,538532,207550,725562,896566,474575,494576,985605,362635,274601,744618,538622,626571,793631,300188,712199,450219,905269,102246,586223,631171,699154,531130,678127,984103,791129,826111,549104,73672,41237,25140,299060,356075,97775,977112,559112,55999,29499,294109,014109,014124,367124,36735,36035,36027,81827,81838,22338,22328,05328,05331,34431,34422,78722,78729,75129,75125,53225,53243,36143,36122,70422,70429,27829,65512,30512,30514,06503,6883,6883,608
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
546
0
255
0
520
0
419
0
378
0
396
0
425
0
406
0
240
0
246
0
226
0
114
0
52
0
51
51
52
52
53
53
54
50
37
23
9
1,805
862
855
2,065
4,580
5,141
5,251
5,826
6,210
6,872
7,116
6,401
6,475
6,480
7,262
7,204
7,065
7,179
6,926
7,209
5,782
6,210
5,678
4,652
0
0
004,6525,6786,2105,7827,2096,9267,1797,0657,2047,2626,4806,4756,4017,1166,8726,2105,8265,2515,1414,5802,0658558621,8059233750545353525251510520114022602460240040604250396037804190520025505460000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
316
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
63
50
37
23
9
0
0
0
0
4,580
5,141
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000005,1414,580000092337506300000000000000031600000000000000000000000000000000
       Accounts payable 
2,766
3,042
3,042
0
9,568
9,711
9,711
11,805
25,431
18,631
18,631
13,293
13,293
23,588
23,588
13,425
13,425
11,850
11,850
15,130
15,130
12,556
12,556
22,012
22,012
16,107
16,107
18,068
18,068
15,739
15,739
22,093
22,093
20,449
20,449
29,365
29,365
23,047
23,047
0
30,007
0
32,823
32,775
29,113
24,223
22,673
27,749
31,209
46,964
36,686
48,437
47,122
55,657
69,141
80,721
68,038
69,880
86,216
156,254
142,510
169,477
179,432
157,259
171,316
161,867
151,721
145,260
134,304
134,668
160,746
154,745
133,298
155,949
131,074
121,129
134,653
145,551
128,312
128,312145,551134,653121,129131,074155,949133,298154,745160,746134,668134,304145,260151,721161,867171,316157,259179,432169,477142,510156,25486,21669,88068,03880,72169,14155,65747,12248,43736,68646,96431,20927,74922,67324,22329,11332,77532,823030,007023,04723,04729,36529,36520,44920,44922,09322,09315,73915,73918,06818,06816,10716,10722,01222,01212,55612,55615,13015,13011,85011,85013,42513,42523,58823,58813,29313,29318,63118,63125,43111,8059,7119,7119,56803,0423,0422,766
       Other Current Liabilities 
736
536
536
0
1,530
594
594
14,678
675
383
383
27,447
27,447
850
850
15,796
15,724
10,682
2,014
15,694
15,650
15,078
15,078
15,833
15,789
11,315
11,271
16,867
15,858
108,222
107,455
86,681
3,073
78,599
3,082
82,968
3,989
52,816
52,344
0
3,271
0
3,255
3,146
3,441
3,195
2,862
2,851
1,701
1,944
2,062
106,071
2,024
1
861
867
1
1,168
1,030
1,031
9,159
27,868
28,578
15,394
14,398
2,277
713
593
5,100
3,039
724
873
16,400
9,857
7,154
1,764
32,648
0
0
0032,6481,7647,1549,85716,4008737243,0395,1005937132,27714,39815,39428,57827,8689,1591,0311,0301,168186786112,024106,0712,0621,9441,7012,8512,8623,1953,4413,1463,25503,271052,34452,8163,98982,9683,08278,5993,07386,681107,455108,22215,85816,86711,27111,31515,78915,83315,07815,07815,65015,6942,01410,68215,72415,79685085027,44727,44738338367514,6785945941,5300536536736
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,749
0
4,188
0
3,488
0
8,502
0
7,231
0
6,879
0
7,319
0
6,631
0
7,868
0
8,922
0
7,678
0
3,988
0
3,976
0
4,509
5,007
5,103
246,006
225,175
204,445
220,846
196,680
168,651
0
102,592
106,888
72,103
28,227
5,342
24,995
25,769
2,685,171
2,621,158
2,529,739
2,459,763
2,407,260
2,412,102
2,308,235
2,190,159
2,139,110
1,983,324
1,890,830
1,842,462
1,749,512
1,685,787
1,544,664
1,463,319
1,385,740
1,133,607
1,084,157
1,015,291
1,015,2911,084,1571,133,6071,385,7401,463,3191,544,6641,685,7871,749,5121,842,4621,890,8301,983,3242,139,1102,190,1592,308,2352,412,1022,407,2602,459,7632,529,7392,621,1582,685,17125,76924,9955,34228,22772,103106,888102,5920168,651196,680220,846204,445225,175246,0065,1035,0074,50903,97603,98807,67808,92207,86806,63107,31906,87907,23108,50203,48804,18804,7490000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,457
19,661
19,558
18,856
20,384
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000020,38418,85619,55819,66120,4570000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
214
63
63
11,875
23,637
18,110
18,110
4,698
4,698
4,252
4,252
3,392
3,392
2,531
2,531
1,960
1,960
2,704
2,704
3,672
3,672
3,813
3,813
4,465
4,465
4,381
4,381
5,079
5,079
6,074
6,074
5,319
5,319
3,848
3,848
0
3,860
0
4,420
4,931
5,040
245,956
225,138
204,423
220,837
196,680
168,651
139,910
102,592
106,888
72,103
28,227
5,342
4,586
5,312
2,665,510
2,601,600
2,510,883
2,439,379
2,385,310
2,389,066
2,286,059
2,168,730
2,119,982
1,963,669
1,872,541
1,825,587
1,733,753
1,671,095
0
0
0
0
0
0
0000001,671,0951,733,7531,825,5871,872,5411,963,6692,119,9822,168,7302,286,0592,389,0662,385,3102,439,3792,510,8832,601,6002,665,5105,3124,5865,34228,22772,103106,888102,592139,910168,651196,680220,837204,423225,138245,9565,0404,9314,42003,86003,8483,8485,3195,3196,0746,0745,0795,0794,3814,3814,4654,4653,8133,8133,6723,6722,7042,7041,9601,9602,5312,5313,3923,3924,2524,2524,6984,69818,11018,11023,63711,87563632140000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,460
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,872
0
0
0
13,334
0
0
0
11,796
0
0
0
0
0
0
0
0
0
0
000000000011,79600013,33400014,8720000000000000000000000000003,46000000000000000000000000000000000
> Total Stockholder Equity
10,367
27,846
27,846
27,846
61,136
55,798
55,798
109,542
109,542
104,188
104,188
98,626
98,626
88,231
88,231
84,324
84,324
79,241
79,241
108,877
108,877
103,181
103,181
148,506
148,507
118,292
118,292
118,376
118,376
112,340
112,340
118,447
118,447
168,012
168,012
167,137
167,136
225,015
225,015
0
206,135
206,135
443,455
418,790
364,999
728,545
729,800
708,821
758,701
748,150
1,069,026
1,036,932
1,011,984
899,345
885,659
1,188,222
1,214,249
1,175,755
1,143,367
2,535,281
2,875,658
2,840,041
2,773,263
2,712,083
2,670,355
2,701,462
2,663,473
2,617,383
2,643,362
2,646,589
2,646,898
2,690,351
2,526,026
2,564,604
2,583,948
2,621,560
2,795,566
2,895,008
2,910,295
2,910,2952,895,0082,795,5662,621,5602,583,9482,564,6042,526,0262,690,3512,646,8982,646,5892,643,3622,617,3832,663,4732,701,4622,670,3552,712,0832,773,2632,840,0412,875,6582,535,2811,143,3671,175,7551,214,2491,188,222885,659899,3451,011,9841,036,9321,069,026748,150758,701708,821729,800728,545364,999418,790443,455206,135206,1350225,015225,015167,136167,137168,012168,012118,447118,447112,340112,340118,376118,376118,292118,292148,507148,506103,181103,181108,877108,87779,24179,24184,32484,32488,23188,23198,62698,626104,188104,188109,542109,54255,79855,79861,13627,84627,84627,84610,367
   Retained Earnings -118,852-133,080-228,274-403,242-440,792-459,821-496,689-326,905-367,381-366,119-367,205-391,311-345,101-306,881-334,701-297,098-235,224-150,597-109,223-3,907-376,518-340,020-297,779-321,495-343,796-328,620-211,441-186,432-154,553-122,854-112,272-162,048-140,845-139,465-177,317-122,634-97,1420-63,9440-42,6970-100,1070-99,6350-94,7700-101,5990-91,1400-90,1090-60,0790-76,2730-66,8680-78,1170-72,4920000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
45,961
0
-1,947
0
52,875
0
55,073
0
71,463
0
70,950
0
72,056
0
3,199
0
994
0
844
0
217
0
-1,723
0
-1,377
0
-416
-786
-485
-867
-1,057
-1,423
-2,090
-2,059
-2,215
0
-3,014
-2,398
-2,245
-2,239
-2,292
-2,025
-2,240
-2,002
-5,984
-5,582
-5,646
-7,356
-14,096
-13,067
-13,162
-13,194
-11,899
-11,918
-11,806
-11,906
-6,446
-6,505
-6,190
-6,128
-7,091
0
0
00-7,091-6,128-6,190-6,505-6,446-11,906-11,806-11,918-11,899-13,194-13,162-13,067-14,096-7,356-5,646-5,582-5,984-2,002-2,240-2,025-2,292-2,239-2,245-2,398-3,0140-2,215-2,059-2,090-1,423-1,057-867-485-786-4160-1,3770-1,72302170844099403,199072,056070,950071,463055,073052,8750-1,947045,9610000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,283,650
2,268,585
2,703,583
2,708,114
2,723,671
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000002,723,6712,708,1142,703,5832,268,5851,283,6500000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.